Functional Interplay Between Collagen Network and Cell Behavior Within Tumor Microenvironment in Colorectal Cancer.
cancer-associated fibroblast
collagen
colorectal cancer
endothelial cell
in vitro model
tumor cell
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2020
2020
Historique:
received:
18
01
2020
accepted:
24
03
2020
entrez:
20
5
2020
pubmed:
20
5
2020
medline:
20
5
2020
Statut:
epublish
Résumé
Colorectal cancer is the second most common cancer diagnosed in men and the third most commonly occurring in women worldwide. Interactions between cells and the surrounding extracellular matrix (ECM) are involved in tumor development and progression of many types of cancer. The organization of the ECM molecules provides not only physical scaffoldings and dynamic network into which cells are embedded but also allows the control of many cellular behaviors including proliferation, migration, differentiation, and survival leading to homeostasis and morphogenesis regulation. Modifications of ECM composition and mechanical properties during carcinogenesis are critical for tumor initiation and progression. The core matrisome consists of five classes of macromolecules, which are collagens, laminins, fibronectin, proteoglycans, and hyaluronans. In most tissues, fibrillar collagen is the major component of ECM. Cells embedded into fibrillar collagen interact with it through their surface receptors, such as integrins and discoidin domain receptors (DDRs). On the one hand, cells incorporate signals from ECM that modify their functionalities and behaviors. On the other hand, all cells within tumor environment (cancer cells, cancer-associated fibroblasts, endothelial cells, and immune cells) synthesize and secrete matrix macromolecules under the control of multiple extracellular signals. This cell-ECM dialog participates in a dynamic way in ECM formation and its biophysical and biochemical properties. Here, we will review the functional interplay between cells and collagen network within the tumor microenvironment during colorectal cancer progression.
Identifiants
pubmed: 32426274
doi: 10.3389/fonc.2020.00527
pmc: PMC7204546
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
527Informations de copyright
Copyright © 2020 Le, Bennasroune, Langlois, Salesse, Boulagnon-Rombi, Morjani, Dedieu and Appert-Collin.
Références
Oncotarget. 2016 Feb 2;7(5):6159-74
pubmed: 26716418
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
Sci Rep. 2017 Mar 09;7:44045
pubmed: 28276469
Mol Oncol. 2016 Jan;10(1):40-58
pubmed: 26304112
Clin Cancer Res. 2013 Nov 1;19(21):5914-26
pubmed: 24052018
J Surg Oncol. 2010 Sep 1;102(3):242-8
pubmed: 20740582
Sci Adv. 2019 May 22;5(5):eaaw1317
pubmed: 31131324
BMC Cancer. 2015 Nov 24;15:929
pubmed: 26603532
J Pathol. 2019 Mar;247(3):293-304
pubmed: 30306567
Clin Cancer Res. 2015 Nov 1;21(21):4892-902
pubmed: 26206869
Proteomics. 2019 Apr;19(8):e1800148
pubmed: 30582284
Mol Cancer Ther. 2011 Aug;10(8):1327-36
pubmed: 21610170
Biomark Med. 2012 Jun;6(3):297-300
pubmed: 22731903
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Nat Commun. 2018 Nov 14;9(1):4783
pubmed: 30429478
Oncogene. 2018 Mar;37(9):1205-1219
pubmed: 29242607
Cell Commun Signal. 2018 Jul 2;16(1):36
pubmed: 29966518
Radiother Oncol. 2015 Sep;116(3):510-6
pubmed: 26096850
Pathol Oncol Res. 2012 Apr;18(2):315-23
pubmed: 21938482
Oncotarget. 2016 May 3;7(18):24908-27
pubmed: 27121132
Cell Biol Int. 2020 Feb;44(2):621-629
pubmed: 31736196
Mol Cell Oncol. 2018 Jul 23;5(4):e1465882
pubmed: 30250919
Anticancer Res. 2017 May;37(5):2587-2591
pubmed: 28476831
Cancers (Basel). 2019 May 21;11(5):
pubmed: 31117256
BMC Cancer. 2013 Nov 02;13:518
pubmed: 24180698
Front Oncol. 2015 Mar 23;5:63
pubmed: 25853091
Oncotarget. 2016 May 24;7(21):30295-306
pubmed: 26993598
Ann Coloproctol. 2019 Feb;35(1):36-46
pubmed: 30879282
Mol Cancer Res. 2014 Sep;12(9):1254-66
pubmed: 24829396
Int J Clin Exp Pathol. 2015 Oct 01;8(10):12802-10
pubmed: 26722470
World J Gastroenterol. 2016 Jun 21;22(23):5301-16
pubmed: 27340347
Biomed Pharmacother. 2019 Jun;114:108708
pubmed: 30913493
J Oncol. 2019 Jun 2;2019:5810465
pubmed: 31275381
J Biol Chem. 2008 Mar 14;283(11):6861-8
pubmed: 18201965
Nat Genet. 2015 Apr;47(4):320-9
pubmed: 25706628
Oncotarget. 2014 Jun 30;5(12):3983-95
pubmed: 24980818
J Pathol. 2006 Apr;208(5):662-72
pubmed: 16400631
Mol Cell. 1997 Dec;1(1):13-23
pubmed: 9659899
Cell Tissue Res. 2010 Jan;339(1):269-80
pubmed: 19693543
J Proteomics. 2013 Dec 6;94:473-85
pubmed: 24332065
Br J Cancer. 2014 Oct 14;111(8):1605-13
pubmed: 25137019
Matrix Biol. 2018 Aug;68-69:180-193
pubmed: 29605717
PLoS One. 2014 Sep 12;9(9):e106748
pubmed: 25215506
J Exp Med. 2016 Oct 17;213(11):2315-2331
pubmed: 27697834
J Biomed Opt. 2017 Oct;22(10):1-6
pubmed: 29019178
Oncotarget. 2015 Oct 6;6(30):29929-46
pubmed: 26338966
Eur J Cancer. 2019 Sep;119:179-193
pubmed: 31470251
J Cell Physiol. 2018 Aug;233(8):5937-5948
pubmed: 29244195
Oncotarget. 2014 Nov 15;5(21):10529-45
pubmed: 25301723
Gut. 2003 Oct;52(10):1465-71
pubmed: 12970140
BMC Cancer. 2014 Jul 18;14:518
pubmed: 25037231
Oncogene. 2015 Feb 12;34(7):815-25
pubmed: 24632618
Future Sci OA. 2017 Dec 07;4(3):FSO271
pubmed: 29568561
Clin Cancer Res. 2007 Apr 1;13(7):2082-90
pubmed: 17404090
Cancer Cell. 2012 Nov 13;22(5):571-84
pubmed: 23153532
Pathol Res Pract. 2014 Oct;210(10):668-74
pubmed: 25041835
Br J Cancer. 2018 Feb 6;118(3):435-440
pubmed: 29360819
J Pathol. 2019 May;248(1):103-115
pubmed: 30666650
Eur Heart J. 2011 Nov;32(21):2713-22
pubmed: 21292680
Cancer Res. 2004 Jun 1;64(11):3731-6
pubmed: 15172975
J Clin Invest. 2009 Dec;119(12):3613-25
pubmed: 19920354
Dig Dis Sci. 2018 May;63(5):1219-1228
pubmed: 29497907
Oncogenesis. 2018 Sep 24;7(9):76
pubmed: 30250018
Am J Pathol. 2011 Sep;179(3):1573-85
pubmed: 21827961
J Gastrointest Cancer. 2019 Oct 19;:
pubmed: 31630373
Proc Natl Acad Sci U S A. 2006 Aug 15;103(33):12493-8
pubmed: 16891410
J Biol Chem. 2000 Jan 7;275(1):35-40
pubmed: 10617582
Rep Prog Phys. 2014 Jul;77(7):076602
pubmed: 25006689
PLoS One. 2015 Mar 16;10(3):e0116006
pubmed: 25774665
J Clin Invest. 2006 Oct;116(10):2610-21
pubmed: 17016557
EMBO Mol Med. 2018 Apr;10(4):
pubmed: 29438985
Dig Dis Sci. 2014 Jul;59(7):1529-34
pubmed: 24744180
Front Pharmacol. 2016 Mar 14;7:55
pubmed: 27014069
Cancer Res. 2004 Oct 1;64(19):6973-7
pubmed: 15466189
Clin Cancer Res. 2013 Nov 1;19(21):6006-19
pubmed: 24025712
Sci Rep. 2016 Jul 01;6:28951
pubmed: 27364600
Cell Biol Toxicol. 2018 Dec;34(6):459-469
pubmed: 29478126
Biomark Res. 2013 Mar 07;1(1):16
pubmed: 24252313
Sci Rep. 2019 May 8;9(1):7103
pubmed: 31068603
Colorectal Dis. 2011 Feb;13(2):154-60
pubmed: 19888958
Cancer Res. 2010 Sep 1;70(17):6767-78
pubmed: 20699370
J Cell Physiol. 2017 May;232(5):967-975
pubmed: 27775168
Ann Coloproctol. 2014 Apr;30(2):61-70
pubmed: 24851215
BMC Cancer. 2009 May 07;9:136
pubmed: 19422682
J Surg Res. 2013 Jun 1;182(1):75-84
pubmed: 22959209
Oncogene. 2016 Oct 6;35(40):5224-5236
pubmed: 26973246
Oncogene. 2016 Oct 6;35(40):5263-5271
pubmed: 26996663
Cancer Sci. 2013 Apr;104(4):437-44
pubmed: 23298232
Cell Tissue Res. 2011 Nov;346(2):223-36
pubmed: 21987222